Search results
Results from the WOW.Com Content Network
A June 2020 systematic review found a 29–54% prevalence of olfactory dysfunction for people with COVID-19, [59] while an August 2020 study using a smell-identification test reported that 96% of people with COVID-19 had some olfactory dysfunction, and 18% had total smell loss. [60]
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic. The symptoms of COVID‑19 can vary but often include fever, [7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.
Initial use of ECMO in COVID-19 patients from China early in the pandemic suggested poor outcomes, with less than 90% mortality. [83] In March 2020, the ELSO registry began collecting data on the worldwide use of ECMO for patients with COVID-19 and reporting this data on the ELSO website in real time.
The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be reasonably well-matched,” he says.
Nearly all COVID-19 cases in the United States right now are being caused by one, highly contagious variant called JN.1. The fast-spreading omicron subvariant currently accounts for over 93% of ...
The chief medical officer has appealed to people to stay at home if they have flu-like symptoms and to return to wearing masks on public transport. ... a recent rise in coronavirus hospital ...
Based on the data inputted into the app, researchers estimated that when cases peaked on 1 April 2020, 2.1 million people in the UK aged between 20 and 69 may have had COVID-19, and that as of 23 May 2020, 280,000 people in that age range currently had symptoms consistent with COVID-19. [21] The study also estimates the risk level to health ...
“The symptoms of JN.1 seem to be very similar, if not the same, as others,” said Dr. Molly Fleece, a hospital epidemiologist at University of Alabama at Birmingham Medicine.